Is cabozantinib, a tyrosine kinase inhibitor recently approved for the treatment of metastatic renal cell carcinoma, effective for brain metastases which have been resistant to radiation?
Journal of Medical Case Reports
Original Article: Cabozantinib in Brain Metastases From Renal Cell Carcinoma